We came across a bullish thesis on Lantheus Holdings, Inc. (LNTH) on Substack by Oliver | MMMT Wealth. In this article, we will summarize the bulls’ thesis on LNTH. Lantheus Holdings, Inc. (LNTH)'s share was trading at $94.65 as of Jan 13^th. LNTH’s trailing and forward P/E were 15.72 and 12.27 respectively according to Yahoo Finance.

A supportive smile shared between a care facility staff member and a resident with Alzheimer's or Dementia.

LNTH, a radiopharmaceutical company, represents a high-growth, high-potential opportunity for risk-seeking investors, with its innovative portfolio and strong positioning in oncology and Alzheimer’s imaging markets. Its flagship product, PYLARIFY, accounts for 70% of revenue and leverages PSMA PET imaging to detect prostate cancer with exceptional precision. Alongside PYLARIFY, DEFINITY and TechneLite contribute to the company’s impressive growth trajectory. In the recent quarter, LNTH reported $260 million in net sales, reflecting a 20.6% year-over-year increase and marking the first time it surpassed $1 billion in annual sales. With an EV/Sales multiple of 4.2x, LNTH showcases robust financial momentum.

The PSMA PET imaging market offers compelling tailwinds, driven by its unparalleled precision, while challenges such as cost, infrastructure, and insurance coverage are steadily improving. Additionally, LNTH’s strategic focus on the $2.5 billion Alzheimer’s market further strengthens its investment case. The company is heavily investing in groundbreaking products like MK-6240 and NAV4696, which are undergoing hundreds of clinical trials. LNTH’s recent acquisition of Life Molecular Imaging underscores its commitment to accelerating its Alzheimer’s market entry. LNTH offers an attractive risk/reward profile, combining cutting-edge innovation with strong market tailwinds and significant upside potential.

Lantheus Holdings, Inc. (LNTH) is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 35 hedge fund portfolios held LNTH at the end of the third quarter which was 34 in the previous quarter. While we acknowledge the risk and potential of LNTH as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than LNTH but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock.

Disclosure: None. This article was originally published at Insider Monkey.